MUC2 and colitis: 2′-fucosyllactose (2′-FL) acts as a suppressor of inflammation in DSS-induced colitis, by which regulating gut microbiota composition, improving the recovery of goblet cells and MUC2 secretion, and subsequently affect the TLR4-related inflammatory pathway.